Fonte: Diabetes Care. Unidade: FMRP
Assuntos: DIABETES MELLITUS, HIPOGLICEMIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORDELEAU, Louise et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancer in patients with dysglycemia. Diabetes Care, v. 37, n. 5, p. 1360-1366, 2014Tradução . . Disponível em: https://doi.org/10.2337/dc13-1468. Acesso em: 01 nov. 2024.APA
Bordeleau, L., Yakubovich, N., Dagenais, G. R., Rosenstock, J., Probstfield, J., Yu, P. C., et al. (2014). The association of basal insulin glargine and/or n-3 fatty acids with incident cancer in patients with dysglycemia. Diabetes Care, 37( 5), 1360-1366. doi:10.2337/dc13-1468NLM
Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Yu PC, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC. The association of basal insulin glargine and/or n-3 fatty acids with incident cancer in patients with dysglycemia [Internet]. Diabetes Care. 2014 ; 37( 5): 1360-1366.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2337/dc13-1468Vancouver
Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Yu PC, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC. The association of basal insulin glargine and/or n-3 fatty acids with incident cancer in patients with dysglycemia [Internet]. Diabetes Care. 2014 ; 37( 5): 1360-1366.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2337/dc13-1468
